
Sensei Biotherapeutics SNSE
$ 30.0
-1.64%
Quarterly report 2025-Q3
added 11-14-2025
Country |
|
IPO year |
2021 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
25.1 M |
Market Cap[1] |
$ 754 M |
EBITDA (LTM) |
$ -31.2 M |
P/E (LTM) |
-2.27 |
P/S (LTM) |
- |
EPS (LTM) |
-13.57 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | ||
|
Alector
ALEC
|
$ 2.11 | -13.17 % | $ 217 M | Nasdaq Global Select Market,SPB | ||
|
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | ||
|
Axsome Therapeutics
AXSM
|
$ 163.89 | - | $ 8.15 B | Nasdaq Global Market,SPB | ||
|
BridgeBio Pharma
BBIO
|
$ 64.28 | -3.31 % | $ 12.3 B | Nasdaq Global Select Market,SPB | ||
|
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | ||
|
BioCardia
BCDA
|
$ 1.37 | 5.81 % | $ 29 M | Nasdaq Global Select Market | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | ||
|
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | ||
|
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | ||
|
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | ||
|
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | ||
|
BioLineRx Ltd.
BLRX
|
$ 2.82 | -0.35 % | $ 908 M | Nasdaq Capital Market | ||
|
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | ||
|
BioMarin Pharmaceutical
BMRN
|
$ 59.8 | -3.13 % | $ 11.5 B | Nasdaq Global Select Market,SPB | ||
|
Bristol-Myers Squibb Company
BMY
|
$ 62.08 | -0.46 % | $ 126 B | NYSE,SPB | ||
|
Benitec Biopharma
BNTC
|
$ 10.93 | 0.23 % | $ 450 M | Nasdaq Capital Market | ||
|
BioNTech SE
BNTX
|
$ 109.33 | -0.82 % | $ 27.2 B | Nasdaq Global Select Market | ||
|
Black Diamond Therapeutics
BDTX
|
$ 2.38 | -3.44 % | $ 131 M | Nasdaq Global Select Market,SPB | ||
|
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | ||
|
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | ||
|
BioXcel Therapeutics
BTAI
|
$ 1.63 | -2.4 % | $ 4.13 M | Nasdaq Global Select Market,SPB | ||
|
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market | ||
|
Burford Capital Limited
BUR
|
$ 8.65 | 2.49 % | $ 1.39 B | NYSE | ||
|
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | ||
|
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX | ||
|
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | ||
|
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | ||
|
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | ||
|
BeyondSpring
BYSI
|
$ 1.34 | -0.87 % | $ 54 M | Nasdaq Capital Market | ||
|
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | ||
|
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | ||
|
Cabaletta Bio
CABA
|
$ 3.34 | 0.61 % | $ 3.9 M | Nasdaq Global Select Market | ||
|
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | ||
|
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | ||
|
Can-Fite BioPharma Ltd.
CANF
|
$ 4.88 | 2.74 % | $ 10.6 B | NYSE American | ||
|
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | ||
|
Capricor Therapeutics
CAPR
|
$ 27.28 | -2.32 % | $ 731 M | Nasdaq Capital Market | ||
|
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | ||
|
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | ||
|
Catalyst Biosciences
CBIO
|
$ 11.67 | -3.47 % | $ 768 M | Nasdaq Capital Market | ||
|
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | ||
|
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | ||
|
C4 Therapeutics
CCCC
|
$ 3.06 | 13.3 % | $ 254 M | Nasdaq Global Select Market | ||
|
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | ||
|
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | ||
|
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | ||
|
Codexis
CDXS
|
$ 0.99 | -2.04 % | $ 72.7 M | Nasdaq Global Select Market | ||
|
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.